GPC3 and hepatocellular carcinoma: A study on a GPC3-targeting peptide (named G12)-modified liposome (GSI-Lip) co-loaded with sorafenib (SF) and IR780 iodide (IR780) showed promising sensitivity and specificity in detecting HCC together with synergistic effects on chemo-photothermal theranostics (103).